IDEAYA Biosciences market cap IDYA
Share price times shares outstanding: what the whole company sells for, since 2019.
- Today, Nov 2, 2026
- $3.1B
- Highest close in our data
- $3.9B
- Aug 2026
IDEAYA Biosciences is worth $3.1B at the close on Nov 2, 2026, at $31.64 a share.
That is up 15% over the last year and up 237% over five years.
Its highest close in our data was $3.9B in Aug 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $3.1B | $2.5B | $3.9B | −1% |
| 2025 | $3.1B | $1.3B | $3.1B | +42% |
| 2024 | $2.2B | $2.2B | $3.4B | −5% |
| 2023 | $2.3B | $664.4M | $2.3B | +162% |
| 2022 | $874.2M | $352.3M | $874.2M | −4% |
| 2021 | $910.1M | $406.7M | $1B | +124% |
| 2020 | $407M | $73M | $453.5M | +135% |
| 2019 | $172.8M | $108.4M | $186.2M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest IDEAYA Biosciences' size, closest first, today.
| Company | Market cap |
|---|---|
| IDYAIDEAYA Biosciences | $3.1B |
| NRIXNurix Therapeutics | $2.8B |
| OGNOrganon | $3.6B |
| LQDALiquidia | $3.7B |
| ARQTArcutis Biotherapeutics | $3.9B |
| PBHPrestige Consumer Healthcare | $2.4B |
| HRMYHarmony Biosciences | $2.2B |
| INDVIndivior Pharmaceuticals | $4.3B |
| ANIPANI Pharmaceuticals | $1.6B |
| PAHCPhibro Animal Health | $1.6B |
| LGNDLigand Pharmaceuticals | $6.1B |
| Peer median | $3.2B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on IDEAYA Biosciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.